NC-CHILTERN
Chiltern , a leading global contract research organization (CRO), announced it has signed a purchase agreement to acquire Theorem Clinical Research , another leading global CRO.
“This is a direct response to client demand for a clinical research partner that can provide scientific and operating strengths globally, in a responsive and flexible way,” said Dr. Jim Esinhart , Chiltern CEO. “This transaction will bring together more than 3,700 people in more than 45 countries dedicated to the philosophy of “Designed Around You.”
“Chiltern and Theorem have carved out complementary niches, even across key geographies,” said Dr. John Potthoff , Theorem president and CEO. “In key areas, our capabilities will dovetail into current Chiltern operations — this is a mutually beneficial deal.”
The combined company will operate under the name Chiltern and will gain global reach — most notably in China and Japan — as well as new service offerings for medical devices and diagnostics, clinical analytics and clinical supplies.
The planned transaction between the two organizations is subject to customary regulatory and closing conditions. Both companies will follow antitrust guidelines and continue to function as separate and independent entities until the acquisition is approved. The transaction is expected to close within the next several weeks.
About Chiltern:
Chiltern is a leading global CRO that listens to client needs in order to customize solutions for the biopharma industry. With 34 years in service, Chiltern delivers from three specialized business units: Chiltern Biopharma, with deep therapeutic expertise in respiratory, anti-infectives/vaccines, ophthalmology, dermatology and other specialty areas; Chiltern Oncology, led by physicians, scientists and clinicians to uniquely manage all phases of hematologic and oncologic clinical drug development; and Chiltern Source, a world leader in tailored relationships for FSP, resourcing and staffing solutions. Chiltern’s 2,200 engaged professionals work across 45 countries to deliver flexible, responsive solutions that are “Designed Around You.”
Further information is available at: http://www.chiltern.com/ .
About Theorem Clinical Research:
Theorem Clinical Research is a global provider of comprehensive clinical services with staff throughout the Americas, Europe and Asia-Pacific and a client base comprised of the world’s leading biopharmaceutical and medical device companies. With industry-leading experts, unparalleled therapeutic expertise and innovative, groundbreaking technology, Theorem is focused on analytic-based development, combination trials and personal data applications to simplify complex trials.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150806005066/en/
Contact:
For Chiltern
Lea Studer, +1 308-237-5567
SCORR Marketing
lea@scorrmarketing.com
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
AACR 2025: Crown Bioscience Unveils 3D Bone Marrow Niche In Vitro Models for Oncology Preclinical Screening in Hematological Malignancies28.4.2025 15:30:00 CEST | Press release
High-content imaging-based 3D models advance hematological cancer research with clinically relevant tumor modeling Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and a part of JSR Life Sciences and Japan-based JSR Corporation, today unveils at AACR 2025 its cutting-edge 3D bone marrow niche (BMN) in vitro models to advance hematological cancer research. Providing both the physical environment (cell-cell interactions), and the growth factor cocktail that hematological cancer cells require to thrive and proliferate, this innovative model provides a dynamic platform for studying liquid malignancies such as acute myeloid leukemia (AML) and multiple myeloma (MM). The system incorporates key cellular components—stromal cells and endothelial cells—within biofunctional hydrogels seeded with patient-derived tumor cells, optionally supplemented with autologous immune cells. By accurately capturing the essential tumor microenvironment, the niche
University of Melbourne’s Mobile Learning Unit (MLU) Selects Rimini Solutions™ for Salesforce to Manage and Enhance its eLearning Platform28.4.2025 15:00:00 CEST | Press release
Rimini Street to provide managed and professional services for the highly customized and integrated Salesforce environment which serves as the core of MLU’s curriculum and case management processes Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced that the Mobile Learning Unit (MLU) at the University of Melbourne has selected Rimini Manage™ and Rimini Consult™ for Salesforce as its strategy to bring stability and enhancement to its eLearning platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428060618/en/ University of Melbourne’s Mobile Learning Unit (MLU) Selects Rimini Solutions™ for Salesforce to Manage and Enhance its eLearning Platform The MLU is on a mission to make learning accessible, engaging and simplified. Through the successful launch o
Svante and Mercer International Advance Carbon Capture Project at Alberta Pulp Mill28.4.2025 15:00:00 CEST | Press release
Svante Technologies Inc. (Svante), a leader in carbon capture and removal technology, today announced that its joint carbon capture and storage project with Mercer International Inc. (Mercer) has advanced to the Front-end Engineering and Design Phase 2 (FEL-2). Also known as Pre-FEED, this phase involves engineering, cost estimation, and risk analysis to evaluate the project's commercial viability. Mercer is a global producer of sustainably sourced forest products, including pulp, lumber, mass timber, biomass-based green energy, and bioextractives. The carbon capture project targets biogenic CO2 emissions from Mercer’s Peace River pulp mill, where the biomass (fibre) is sourced from sustainably managed forests. Advancing to the Pre-FEED stage will support further development of the integrated design, cost estimates, and risk assessments—key steps toward a final investment decision and potential implementation. This milestone reflects the growing momentum for carbon capture solutions wi
Generix Announces New AI-Powered Resource Management System (RMS) to Intelligently Optimize All Warehouse Resources28.4.2025 15:00:00 CEST | Press release
Generix, a global business software company offering an expansive portfolio of SaaS solutions for supply chain, finance, commerce, and B2B integration, today announces the launch of Generix Resource Management Systems (RMS), a new AI-powered application that optimizes all warehouse resources through intelligent forecasting, planning, and analytics – all in a single environment. As many warehouse management teams struggle to keep pace with supply chain disruptions with error-prone, disparate manual tools, Generix RMS provides the precise forecasting and planning capabilities needed to control labor costs, maximize resource utilization, and improve visibility into capacity. “In a world dominated by unpredictability, we know that the stakes are too high, and supply chains are too complex to simply rely on spreadsheets for planning and managing all warehouse resources,” stated Si-Mohamed Saïd, Chief Product & Marketing Officer, Generix. “The new Generix RMS has the unique ability to bring
Seoul Semiconductor: Unified Patent Court Orders Recall of Products Infringing Essential Micro LED Patents28.4.2025 15:00:00 CEST | Press release
Seoul Semiconductor Co., Ltd. (KOSDAQ: 046890), a leading global innovator of LED products and technology, announced that the Local Division Paris of the Unified Patent Court (UPC), which has jurisdiction across 18 European countries, has issued a judgment that Laser Components SAS infringed Seoul Semiconductor affiliate’s core optical semiconductor patent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428172182/en/ Comparison of Structures: Conventional LED vs. 2nd generation LED (Image: Seoul Semiconductor) The court ordered an immediate ban on sales, as well as the recall and destruction of infringing products. This ruling is Seoul’s second victory at the UPC, following its October 2024 judgment prohibiting the sales of products infringing Seoul’s patents across eight countries — a first in the LED industry. Laser Components is a global distributor offering electronic components across U.S., Europe, and Canada. This c
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum